Success of a Transdisciplinary Peri-Operative Pathway for Patients Undergoing Emergency Laparotomy During the COVID-19 Pandemic: A CUSUM Analysis.

Publication date: Jun 25, 2025

Emergency laparotomy (EL) is associated with high post-operative morbidity. This study aims to evaluate the sustainability of our peri-operative pathway for EL (Emergency Laparotomy Pathway (ELAP)) during the COVID-19 pandemic. This is a single-center retrospective study on patients who underwent EL following ELAP implementation from Jan 2019-Dec 2022. Exclusion criteria were EL for trauma or vascular surgery. The cohort was divided based on the COVID-19 pandemic (COVID was defined from 7 Feb 2020-25 Apr 2022). Cumulative sum (CUSUM) analysis was used to assess the chronologic performance of ELAP. Our primary outcomes were efficiency outcomes (time to surgery, presence of senior surgeon/anaesthetist in theatre and post-operative geriatric review). Our secondary outcomes were post-operative complications, major morbidity, and 30-day mortality. There were 564 patients (30. 5% pre-COVID, 52. 1% COVID, 17. 4% post-COVID). The median age was 66. 0 years, and 57. 6% had ASA score ≥ 3. The commonest indication for EL was intestinal obstruction (56. 9%). Overall major morbidity was 14. 0%, and 30-day mortality was 2. 8%. CUSUM analysis showed two phases-exploration phase (Case 1-158) and proficiency phase (Case 159-564); an inflection point was noted following the exploration phase, which showed a more sustained performance in achieving post-operative geriatric review and absence of post-operative complications or major morbidity. There was no observed relationship between COVID-19 and the performance of ELAP in both efficiency and clinical outcomes. The good performance of ELAP was sustained at 4 years following its initial implementation despite the COVID-19 pandemic, which resulted in major disruptions to healthcare delivery.

Concepts Keywords
4years emergency surgery
Anaesthetist frailty
Covid laparotomy
High peri‐operative care
quality improvement

Semantics

Type Source Name
drug DRUGBANK Spinosad
disease MESH Emergency
disease MESH COVID-19 Pandemic
disease MESH morbidity
disease MESH complications
drug DRUGBANK Acetylsalicylic acid
disease MESH intestinal obstruction
disease MESH frailty
disease IDO quality

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *